These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 22410344)
1. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability. Ciolkowski M; Pałecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344 [TBL] [Abstract][Full Text] [Related]
2. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes. Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678 [TBL] [Abstract][Full Text] [Related]
3. Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates. Szulc A; Signorelli M; Schiraldi A; Appelhans D; Voit B; Bryszewska M; Klajnert-Maculewicz B; Fessas D Int J Pharm; 2015 Nov; 495(2):940-7. PubMed ID: 26456295 [TBL] [Abstract][Full Text] [Related]
4. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity. Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301 [TBL] [Abstract][Full Text] [Related]
5. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer. Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266 [TBL] [Abstract][Full Text] [Related]
6. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin. Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144 [TBL] [Abstract][Full Text] [Related]
7. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells. Ziemba B; Halets I; Shcharbin D; Appelhans D; Voit B; Pieszynski I; Bryszewska M; Klajnert B J Biomed Mater Res A; 2012 Nov; 100(11):2870-80. PubMed ID: 22623362 [TBL] [Abstract][Full Text] [Related]
8. Stability of dendriplexes formed by anti-HIV genetic material and poly(propylene imine) dendrimers in the presence of glucosaminoglycans. Szewczyk M; Drzewinska J; Dzmitruk V; Shcharbin D; Klajnert B; Appelhans D; Bryszewska M J Phys Chem B; 2012 Dec; 116(50):14525-32. PubMed ID: 23199071 [TBL] [Abstract][Full Text] [Related]
9. Genotoxicity of poly(propylene imine) dendrimers. Ziemba B; Matuszko G; Appelhans D; Voit B; Bryszewska M; Klajnert B Biopolymers; 2012 Aug; 97(8):642-8. PubMed ID: 22605555 [TBL] [Abstract][Full Text] [Related]
11. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease. Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423 [TBL] [Abstract][Full Text] [Related]
12. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI. Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871 [TBL] [Abstract][Full Text] [Related]
13. On the ability of PAMAM dendrimers and dendrimer/DNA aggregates to penetrate POPC model biomembranes. Ainalem ML; Campbell RA; Khalid S; Gillams RJ; Rennie AR; Nylander T J Phys Chem B; 2010 Jun; 114(21):7229-44. PubMed ID: 20455596 [TBL] [Abstract][Full Text] [Related]
14. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers. Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354 [TBL] [Abstract][Full Text] [Related]
15. Influence of surface groups on poly(propylene imine) dendrimers antiprion activity. McCarthy JM; Rasines Moreno B; Filippini D; Komber H; Maly M; Cernescu M; Brutschy B; Appelhans D; Rogers MS Biomacromolecules; 2013 Jan; 14(1):27-37. PubMed ID: 23234313 [TBL] [Abstract][Full Text] [Related]
16. Understanding the binding interactions between dendrimer and 18 common amino acids by NMR techniques. Wang M; Gong X; Hu J; Yu Y; Chen Q; Cheng Y J Phys Chem B; 2011 Nov; 115(44):12728-35. PubMed ID: 21932783 [TBL] [Abstract][Full Text] [Related]
17. Bundling and aggregation of DNA by cationic dendrimers. Froehlich E; Mandeville JS; Weinert CM; Kreplak L; Tajmir-Riahi HA Biomacromolecules; 2011 Feb; 12(2):511-7. PubMed ID: 21192723 [TBL] [Abstract][Full Text] [Related]
18. Interaction of heme proteins with poly(propyleneimine) dendrimers in layer-by-layer assembly films under different pH conditions. He P; Li M; Hu N Biopolymers; 2005 Dec; 79(6):310-23. PubMed ID: 16127662 [TBL] [Abstract][Full Text] [Related]
19. In vivo toxicity of poly(propyleneimine) dendrimers. Ziemba B; Janaszewska A; Ciepluch K; Krotewicz M; Fogel WA; Appelhans D; Voit B; Bryszewska M; Klajnert B J Biomed Mater Res A; 2011 Nov; 99(2):261-8. PubMed ID: 21976451 [TBL] [Abstract][Full Text] [Related]
20. Studying complexes between PPI dendrimers and Mant-ATP. Szulc A; Appelhans D; Voit B; Bryszewska M; Klajnert B J Fluoresc; 2013 Mar; 23(2):349-56. PubMed ID: 23306952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]